| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $75.4M | — | +27.5% |
| Cost of Revenue | $32.6M | — | +26.1% |
| Gross Profit | $42.8M | — | +28.7% |
| R&D Expense | $579K | — | -27.4% |
| SG&A Expense | $34.8M | — | +22.4% |
| Operating Income | $4.3M | — | +11.8% |
| Pre-tax Income | $4.0M | — | +9.0% |
| Income Tax | $1.3M | — | +34.2% |
| Net Income | $2.6M | — | -1.6% |
| EPS (Basic) | $0.07 | — | +0.0% |
| EPS (Diluted) | $0.06 | — | +0.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $9.8M | -27.7% | -3.9% |
| Accounts Receivable | $31.2M | +21.9% | +16.4% |
| Inventory | $5.2M | +2.7% | +14.9% |
| Current Assets | $49.8M | +2.7% | +1.4% |
| Total Assets | $197.4M | -0.9% | +10.8% |
| Current Liabilities | $40.7M | -0.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $8.1M | — | +182.8% |
| Capital Expenditures | $6.7M | — | -56.6% |
| Investing Cash Flow | -$5.5M | — | +35.7% |
| Financing Cash Flow | -$6.3M | — | -271.2% |
| Free Cash Flow | $1.4M | — | +110.8% |
| +14.7% |
| Long-term Debt | $8.3M | -26.2% | +136.1% |
| Total Liabilities | $51.6M | -7.3% | +24.8% |
| Stockholders' Equity | $143.9M | +1.6% | +6.8% |